ARGX
Price
$722.71
Change
+$16.30 (+2.31%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
43.46B
56 days until earnings call
PRTC
Price
$15.82
Change
-$0.68 (-4.12%)
Updated
Sep 3 closing price
Capitalization
379.79M
Interact to see
Advertisement

ARGX vs PRTC

Header iconARGX vs PRTC Comparison
Open Charts ARGX vs PRTCBanner chart's image
argenx SE
Price$722.71
Change+$16.30 (+2.31%)
Volume$5.25K
Capitalization43.46B
PureTech Health
Price$15.82
Change-$0.68 (-4.12%)
Volume$3.32K
Capitalization379.79M
ARGX vs PRTC Comparison Chart in %
Loading...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARGX vs. PRTC commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGX is a Hold and PRTC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ARGX: $706.41 vs. PRTC: $16.50)
Brand notoriety: ARGX and PRTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARGX: 79% vs. PRTC: 247%
Market capitalization -- ARGX: $43.46B vs. PRTC: $379.79M
ARGX [@Biotechnology] is valued at $43.46B. PRTC’s [@Biotechnology] market capitalization is $379.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARGX’s FA Score shows that 1 FA rating(s) are green whilePRTC’s FA Score has 1 green FA rating(s).

  • ARGX’s FA Score: 1 green, 4 red.
  • PRTC’s FA Score: 1 green, 4 red.
According to our system of comparison, ARGX is a better buy in the long-term than PRTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARGX’s TA Score shows that 5 TA indicator(s) are bullish while PRTC’s TA Score has 4 bullish TA indicator(s).

  • ARGX’s TA Score: 5 bullish, 4 bearish.
  • PRTC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ARGX is a better buy in the short-term than PRTC.

Price Growth

ARGX (@Biotechnology) experienced а -0.24% price change this week, while PRTC (@Biotechnology) price change was -15.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

ARGX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARGX($43.5B) has a higher market cap than PRTC($380M). ARGX has higher P/E ratio than PRTC: ARGX (36.74) vs PRTC (9.31). ARGX YTD gains are higher at: 14.863 vs. PRTC (-10.618).
ARGXPRTCARGX / PRTC
Capitalization43.5B380M11,447%
EBITDA690MN/A-
Gain YTD14.863-10.618-140%
P/E Ratio36.749.31395%
Revenue3.05BN/A-
Total Cash3.93BN/A-
Total Debt43.2MN/A-
FUNDAMENTALS RATINGS
ARGX: Fundamental Ratings
ARGX
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
38
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARGXPRTC
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
69%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
62%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 6 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GMOI30.94-0.10
-0.32%
GMO International Value ETF
MAGA52.15-0.27
-0.52%
Point Bridge America First ETF
VMO9.17-0.06
-0.65%
Invesco Municipal Opportunity Trust
XCOR75.26-0.59
-0.78%
FundX ETF
ESGV113.63-0.93
-0.81%
Vanguard ESG US Stock ETF

ARGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ALNY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
-0.81%
ALNY - ARGX
50%
Loosely correlated
+0.11%
MTVA - ARGX
43%
Loosely correlated
+0.44%
IONS - ARGX
40%
Loosely correlated
+34.84%
ROIV - ARGX
39%
Loosely correlated
+3.86%
APLS - ARGX
37%
Loosely correlated
+2.18%
More

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and IRON have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and IRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
-3.34%
IRON - PRTC
32%
Poorly correlated
+2.94%
ZLAB - PRTC
30%
Poorly correlated
+0.73%
AUTL - PRTC
28%
Poorly correlated
-6.00%
MDWD - PRTC
27%
Poorly correlated
-0.60%
ARGX - PRTC
26%
Poorly correlated
-0.81%
More